BADANIA KONTROLOWANE i CASE STUDIES
AOTI jest zaangażowana w dostarczanie najsilniejszych dowodów naukowych o skuteczności, jakości klinicznej i jakości życia pacjentów w naszej unikatowej Miejscowej Terapii Tlenem - Topical Wound Oxygen (TWO2).
Poniższa tabela podsumowuje wyczerpująco opublikowane już dowody kliniczne na temat przydatności terapii TWO2. Dodatkowo, firma jest w trakcie prowadzenia dalszych badań dla różnych rodzajów ran, w tym wieloośrodkowej, wielonarodowej, kontrolowanej z użyciem placebo, kontrolowanej losowo próby 220 pacjentów, aby dalej badać kliniczne wyniki i oszczędności w leczeniu pacjentów z ranami przewlekłymi różnego typu i etiologii.
Author |
Journal |
Study Type |
No. of Patients |
Ulcer |
Outcome |
Tawfick, W et al |
Vascular and Endovascular Surgery |
Controlled |
132 |
Venous |
Mean reduction in ulcer surface area at 12 weeks was 96% with 76% of ulcers |
Blackman E et al |
Ostomy Wound Management |
Prospective Controlled Study |
28 |
Diabetic |
82.4% of ulcers completely healed at 12 weeks |
Ichioka S et al |
Wounds International |
Case Series |
6 |
Pressure & Diabetic |
Improved ulcer healing |
Aburto et al |
Journal of Wound |
Randomized Controlled Trial |
40 |
Diabetic & Venous |
Diabetic ulcers 90% healing in 12 weeks |
Sultan S et al |
European Journal of Vascular and Endovascular Surgery |
Parallel study |
83 |
Venous |
80% ulcers healed at 12 weeks |
Japour C et al |
Desert Foot Conference Proceedings |
Case Series |
5 |
Diabetic |
Average time to 100% closure was 3.4 months |
Derk F et al |
Desert Foot Conference Proceedings |
Case Series |
9 |
Diabetic & Dehiscence |
Average time to 100% closure was 12.7 weeks |
Levine B et al |
Desert Foot Conference Proceedings |
Case Series |
14 |
Diabetic & Venous |
Average time to 100% closure was 11.5 weeks |
Kallianen LK et al |
Pathophysiology |
Case series |
32 |
Mixed |
75% closure rate. No side effects |
Edsberg LE et al |
Ostomy and Wound Management |
Randomized Controlled Trial |
8 |
Pressure |
Healing of all wounds |
Landau Z et al |
Yale Journal Biology & Medicine |
Prospective open study |
100 |
Diabetic |
81% Healing |
Heng MC et al |
Ostomy and Wound Management |
Prospective Randomized study |
40 |
Pressure |
90% closure rate |
Heng MC et al |
Ostomy and Wound Management |
Prospective Study |
15 |
Pressure |
Overall improvement in ulcer size over time |
Landau Z et al |
Arch Orthopedic Trauma Surgery |
Prospective study |
50 |
Diabetic |
86% closure rate |
Heng MC et al |
American Journal Dermatopatho. |
Case series |
6 |
Pressure |
Some clinical improvement |
Ignacio DR et al |
Journal American Podiatry Asso. |
Case series |
15 |
Mixed |
73% healing rate |
Heng MC et al |
Archives Dermatology |
Prospective non- randomized study |
6 |
Necrotic Pressure |
100% healing in TOT group |
Diamond E et al |
Journal American Podiatry Assoc |
Case series |
11 |
Mixed |
100% healing |
Olejniezak S |
Medical Times |
Meta-Analysis Self Control |
174 |
Mixed |
Very Effective/ Favorable Results |
Fischer BH |
Journal Dermatological Surgery |
Case series |
30 |
Mixed |
Overall positive results |
Fischer BH |
Lancet |
Case series |
52 |
Mixed |
Positive results |